Literature DB >> 28455419

CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer.

Dingzhi Wang1, Haiyan Sun2, Jie Wei1, Bo Cen1, Raymond N DuBois3,4.   

Abstract

Emerging evidence suggests that the primary tumor influences the development of supportive metastatic microenvironments, referred to as premetastatic niches, in certain distant organs before arrival of metastatic cells. However, the mechanisms underlying the contributions of the primary tumor to premetastatic niche formation are not fully understood. Here, we demonstrate that colorectal carcinoma cells secrete VEGFA, which stimulates tumor-associated macrophages to produce CXCL1 in the primary tumor. Elevation of CXCL1 in premetastatic liver tissue recruited CXCR2-positive myeloid-derived suppressor cells (MDSC) to form a premetastatic niche that ultimately promoted liver metastases. Importantly, premetastatic liver-infiltrating MDSCs induced tumor cell survival without involvement of innate or adaptive immune responses. Our study provides the first evidence that primary malignant cell-secreted VEGFA stimulates tumor-associated macrophages to produce CXCL1, which recruits CXCR2-positive MDSCs to form a premetastatic niche to promote liver metastases. Our findings not only shed light on how the tumor microenvironment contributes to premetastatic niche formation at distant sites, but they also provide comprehensive insights into how MDSCs are recruited to other organs where they contribute to metastatic spread of disease. Moreover, our work also provides a rationale for development of CXCR2 antagonists to inhibit or prevent metastatic spread of disease. Cancer Res; 77(13); 3655-65. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28455419      PMCID: PMC5877403          DOI: 10.1158/0008-5472.CAN-16-3199

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition.

Authors:  Dingcheng Gao; Natasha Joshi; Hyejin Choi; Seongho Ryu; Mary Hahn; Raul Catena; Helen Sadik; Pedram Argani; Patrick Wagner; Linda T Vahdat; Jeffrey L Port; Brendon Stiles; Saraswati Sukumar; Nasser K Altorki; Shahin Rafii; Vivek Mittal
Journal:  Cancer Res       Date:  2012-01-26       Impact factor: 12.701

2.  The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis.

Authors:  Bernhard Mlecnik; Gabriela Bindea; Amos Kirilovsky; Helen K Angell; Anna C Obenauf; Marie Tosolini; Sarah E Church; Pauline Maby; Angela Vasaturo; Mihaela Angelova; Tessa Fredriksen; Stéphanie Mauger; Maximilian Waldner; Anne Berger; Michael R Speicher; Franck Pagès; Viia Valge-Archer; Jérôme Galon
Journal:  Sci Transl Med       Date:  2016-02-24       Impact factor: 17.956

3.  GROα promotes invasion of colorectal cancer cells.

Authors:  Hideo Ogata; Akira Sekikawa; Hidetsugu Yamagishi; Kazuhito Ichikawa; Shigeki Tomita; Johji Imura; Yuichi Ito; Masanori Fujita; Masahiro Tsubaki; Hiroyuki Kato; Takahiro Fujimori; Hirokazu Fukui
Journal:  Oncol Rep       Date:  2010-12       Impact factor: 3.906

4.  Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

Authors:  Rachel F Gabitass; Nicola E Annels; Deborah D Stocken; Hardev A Pandha; Gary W Middleton
Journal:  Cancer Immunol Immunother       Date:  2011-06-05       Impact factor: 6.968

5.  Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies.

Authors:  Austin Duffy; Fei Zhao; Lydia Haile; Jaba Gamrekelashvili; Suzanne Fioravanti; Chi Ma; Tamar Kapanadze; Kathryn Compton; William D Figg; Tim F Greten
Journal:  Cancer Immunol Immunother       Date:  2012-08-22       Impact factor: 6.968

6.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Authors:  C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

7.  Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation.

Authors:  Shu Wang; Yuhui Yuan; Lan Liao; Shao-Qing Kuang; Jean Ching-Yi Tien; Bert W O'Malley; Jianming Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-24       Impact factor: 11.205

8.  IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.

Authors:  Susanna Mandruzzato; Samantha Solito; Erika Falisi; Samuela Francescato; Vanna Chiarion-Sileni; Simone Mocellin; Antonio Zanon; Carlo R Rossi; Donato Nitti; Vincenzo Bronte; Paola Zanovello
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

9.  Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.

Authors:  Bin Zhang; Zhijun Wang; Liangliang Wu; Meng Zhang; Wei Li; Jianhua Ding; Jun Zhu; Huafeng Wei; Ke Zhao
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

10.  Tumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated Neutrophils.

Authors:  Ming Yuan; Ha Zhu; Junfang Xu; Yuanyuan Zheng; Xuetao Cao; Qiuyan Liu
Journal:  J Immunol Res       Date:  2016-06-29       Impact factor: 4.818

View more
  106 in total

Review 1.  Role of prostanoids in gastrointestinal cancer.

Authors:  Dingzhi Wang; Raymond N DuBois
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

Review 2.  Salting the Soil: Targeting the Microenvironment of Brain Metastases.

Authors:  Ethan S Srinivasan; Aaron C Tan; Carey K Anders; Ann Marie Pendergast; Dorothy A Sipkins; David M Ashley; Peter E Fecci; Mustafa Khasraw
Journal:  Mol Cancer Ther       Date:  2021-01-05       Impact factor: 6.261

Review 3.  Neutrophils in the Tumor Microenvironment.

Authors:  Lingyun Wu; Sugandha Saxena; Rakesh K Singh
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 4.  Tumor-associated macrophages: role in cancer development and therapeutic implications.

Authors:  Arash Salmaninejad; Saeed Farajzadeh Valilou; Arash Soltani; Sepideh Ahmadi; Yousef Jafari Abarghan; Rhonda J Rosengren; Amirhossein Sahebkar
Journal:  Cell Oncol (Dordr)       Date:  2019-05-29       Impact factor: 6.730

5.  Reactivation of oncogenes involved in G1/S transcription and apoptosis pathways by low dose decitabine promotes HT29 human colon cancer cell growth in vitro.

Authors:  Xiaojie Wang; Pan Chi
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

6.  Cancer progression is mediated by proline catabolism in non-small cell lung cancer.

Authors:  Yating Liu; Chao Mao; Min Wang; Na Liu; Lianlian Ouyang; Shouping Liu; Haosheng Tang; Ya Cao; Shuang Liu; Xiang Wang; Desheng Xiao; Ceshi Chen; Ying Shi; Qin Yan; Yongguang Tao
Journal:  Oncogene       Date:  2020-01-07       Impact factor: 9.867

7.  Differential in vivo biodistribution of 131I-labeled exosomes from diverse cellular origins and its implication for theranostic application.

Authors:  Mohammad H Rashid; Thaiz F Borin; Roxan Ara; Kartik Angara; Jingwen Cai; Bhagelu R Achyut; Yutao Liu; Ali S Arbab
Journal:  Nanomedicine       Date:  2019-08-01       Impact factor: 5.307

8.  Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration.

Authors:  Michael A Casasanta; Christopher C Yoo; Barath Udayasuryan; Blake E Sanders; Ariana Umaña; Yao Zhang; Huaiyao Peng; Alison J Duncan; Yueying Wang; Liwu Li; Scott S Verbridge; Daniel J Slade
Journal:  Sci Signal       Date:  2020-07-21       Impact factor: 8.192

Review 9.  How the ageing microenvironment influences tumour progression.

Authors:  Mitchell Fane; Ashani T Weeraratna
Journal:  Nat Rev Cancer       Date:  2019-12-13       Impact factor: 60.716

10.  Identification of an Unfavorable Immune Signature in Advanced Lung Tumors from Nrf2-Deficient Mice.

Authors:  Di Zhang; Jonathan Rennhack; Eran R Andrechek; Cheryl E Rockwell; Karen T Liby
Journal:  Antioxid Redox Signal       Date:  2018-04-16       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.